Te Ara Waiora-Can the implementation of Human Papillomavirus (HPV) primary self-testing prevent cervical cancer in NZ?: Te Tai Tokerau

Not Applicable

• Conditions: cervical cancer; Cancer - Cervical (cervix)

• Registration Number: ACTRN12621001675819
• Lead Sponsor: Victoria University of Wellington

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-07
• Last Update Posted: 13 December 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 6400

Inclusion Criteria

Maori and non-Maori women aged 25-69 years living in Te Tai Tokerau/Northland region due or over due a cervical smear

Exclusion Criteria

Women who have had treatment for pre-cancer or cervical cancer and are under active follow up by the National Cervical Screening Program for test of cure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the uptake of screening utilising the universal offer of HPV self-testing approach, to the uptake of screening utilising current standard of care: cervical cytology alone determined by collecting and analysing pathology results and auditing of patient management systems[at the conclusion of the 2 year recruitment period 2021-2023]